Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» India
India
Budget 2015: R&D activities in pharma (in India) may get a tax boost
Times of India, India
Wed, 02/25/15 - 09:52 am
R&D
India
Mylan, Gilead in deal for Hepatitis C medications in India
Bizjournals.com
Mon, 02/23/15 - 09:47 am
Mylan Labs
Gilead Sciences
India
hepatitis C
Sovaldi
Harvoni
Lupin says FDA raises concerns over plant at Pithampur
Yahoo/Reuters
Mon, 02/23/15 - 09:36 am
India
Lupin
FDA
drug manufacturing
Indian pharma giants scuffle to snap up injectables maker Claris
BioPharma Dive
Fri, 02/13/15 - 10:30 am
India
injectables
M&A
Claris Lifesciences
Lupin
Cipla
Zydus Cadilla
Pfizer
Hospira acquisition might fetch Pfizer 3 plants in India
Business Standard, India
Sat, 02/7/15 - 10:58 am
Hospira
Pfizer
M&A
India
Why the FDA wants to double inspectors at Indian manufacturing facilities
BioPharma Dive
Fri, 02/6/15 - 10:58 am
FDA
India
drug manufacturing
Big Pharma farms out safety monitoring to $2B-and-growing industry
Fierce Pharma
Tue, 02/3/15 - 08:57 am
India
drug safety
Mylan's women's health biz leaps to fore in emerging markets with $750M Famy purchase
Fierce Pharma
Mon, 02/2/15 - 11:02 am
Mylan Labs
Women's Health
Famy
India
M&A
Sun Pharma gets approval for $4B purchase of Ranbaxy after agreeing to sell off antibiotic
Yahoo/AP
Sat, 01/31/15 - 10:00 am
Sun Pharma
M&A
Ranbaxy
India
FTC
Cheaper Vaccines By Serum Institute Of India To Seize Merck & Co.’s (MRK) Market Share
Bidness Etc.
Wed, 01/28/15 - 11:30 am
India
Serum Institute
generics
vaccines
HPV
Merck
GSK
Cervarix
Gardasil
Gilead to Allow Generic-Drug Makers to Produce New Hepatitis C Treatment
WSJ Online
Mon, 01/26/15 - 07:52 am
generics
Gilead Sciences
hepatitis C
Sovaldi
India
Gilead's appeal for drug patent in India could see protracted case
The Hindu
Sat, 01/17/15 - 11:05 am
Gilead Sciences
India
hepatitis C
Sovaldi
Gilead to appeal India patent ruling on hepatitis C drug
Yahoo/Reuters
Fri, 01/16/15 - 08:11 am
Gilead Sciences
India
patents
Sovaldi
hepatitis C
India Rejects Gilead Patent Bid for Sovaldi Hepatitis C Treatment
WSJ Pharmalot
Thu, 01/15/15 - 08:59 am
India
patents
Gilead Sciences
Sovaldi
hepatitis C
India should develop an enforceable legal framework through the proposed IPR Policy: John Castellani
Business Standard, India
Sun, 01/11/15 - 10:43 am
India
India eases foreign ownership rules for medical device makers
Mass Device
Mon, 12/29/14 - 11:24 am
India
devices
Drug Prices, Generics and M&A: What to Watch in 2015
WSJ Pharmalot
Mon, 12/29/14 - 09:40 am
generics
drug pricing
M&A
India
pay-for-delay
Pharmaceutical Industry Expects to create 45000 more jobs in India in 2015
Equity Bulls
Sat, 12/20/14 - 11:25 am
India
Bayer loses bid to block cheap version of cancer drug in India
FT.com
Fri, 12/12/14 - 12:37 pm
Bayer
India
Nexavar
India's Cadila launches first cheaper copy of world's top-selling drug
Yahoo/Reuters
Tue, 12/9/14 - 07:51 am
India
Cadila
AbbVie
Humira
biosimilars
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »